What is the recommended dose of metronidazole (Flagyl) for pediatric patients?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: December 3, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Metronidazole Dosing for Pediatric Patients

The recommended dose of metronidazole for most pediatric infections is 30-40 mg/kg/day divided every 8 hours, with a maximum of 500 mg per dose. 1

Standard Dosing by Clinical Scenario

General Infections (Anaerobic Coverage)

  • For most anaerobic infections, use 30-40 mg/kg/day divided into three doses (every 8 hours), maximum 500 mg per dose 1
  • Standard treatment duration is 10 days for most infections 1
  • The FDA label specifies 35-50 mg/kg/24 hours divided into three doses for amebiasis 2

Skin and Soft Tissue Infections (Necrotizing Infections)

  • For mixed necrotizing infections requiring anaerobic coverage, use 7.5 mg/kg/dose every 6 hours IV 3
  • This is typically combined with cefotaxime (50 mg/kg/dose every 6 hours) or other broad-spectrum agents 3

Clostridium difficile Infection (CDI)

The dosing differs significantly based on severity:

Non-severe CDI:

  • 7.5 mg/kg/dose three or four times daily (maximum 500 mg per dose) for 10 days 1, 4
  • This applies to both initial episodes and first recurrence 4

Severe CDI:

  • Oral vancomycin is preferred over metronidazole (strong recommendation) 4
  • If metronidazole must be used: 10 mg/kg/dose three times daily IV (maximum 500 mg per dose) 1, 4

Fulminant CDI:

  • Do not use metronidazole as monotherapy 5
  • If used, give IV metronidazole 500 mg every 8 hours concurrently with high-dose oral vancomycin 5

Intra-abdominal Infections

  • Use 30-40 mg/kg/day divided every 8 hours as part of combination therapy 1
  • Should be combined with aminoglycosides, carbapenems, or advanced-generation cephalosporins 1

Inflammatory Bowel Disease (Perianal Crohn's Disease)

  • 10-20 mg/kg/day in divided doses 1

Important Clinical Considerations

Dosing Frequency

  • While traditional dosing is every 6-8 hours, recent pharmacokinetic data supports once-daily dosing (30 mg/kg/dose) for appendicitis, achieving adequate AUC/MIC ratios for Bacteroides fragilis with MIC ≤2 mcg/mL 6
  • However, guideline-recommended dosing remains every 8 hours for most infections 3, 1

Maximum Doses

  • Never exceed 500 mg per individual dose in pediatric patients 1, 4
  • Total daily dose should not exceed 4 grams in a 24-hour period 2

Route of Administration

  • Oral and IV dosing are generally equivalent in bioavailability 2
  • For severe infections, start with IV therapy and transition to oral once clinically improving 7

Common Pitfalls to Avoid

  • Do not use standard adult dosing (500 mg TID) in children—always calculate weight-based dosing 1
  • Do not use metronidazole monotherapy for severe or fulminant CDI—vancomycin is superior 4, 5
  • Do not exceed 500 mg per dose even in larger adolescents 1, 4
  • For CDI, recognize that the dosing is LOWER (7.5 mg/kg/dose) than for other anaerobic infections (10-13 mg/kg/dose) 3, 4

Special Populations

  • In hepatic impairment, reduce doses and monitor closely 2
  • Metronidazole is well-tolerated in children with minimal side effects compared to adults 7
  • Nausea, anorexia, and metallic taste may occur but are generally mild 8

References

Guideline

Pediatric Metronidazole Dosing Guidelines

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Metronidazole Dosing in Pediatric Patients

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Treatment of Fulminant C. difficile Infection

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Treatment of anaerobic infections in children with metronidazole.

Developmental pharmacology and therapeutics, 1983

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.